--- title: "AI for healthcare teams - clinical documents to decision support | Impetora" description: "Custom AI for hospitals, clinics, payers and digital health platforms. Clinical document extraction, patient triage, decision support, medical coding, consent automation. EU AI Act and GDPR Article 9-aligned." url: https://impetora.com/industries/healthcare locale: en dateModified: 2026-04-27 author: Impetora alternates: en: https://impetora.com/industries/healthcare lt: https://impetora.com/lt/sektoriai/sveikatos-prieziura --- # AI for healthcare teams, from clinical document structuring to assistive decision support > AI for healthcare teams is the design and deployment of custom systems that extract clinical data, triage patient communications, support documentation and coding, and surface decision-support evidence while preserving the audit trail that clinicians, regulators and data-protection authorities require. Impetora builds these systems for hospitals, clinics, payers and digital health platforms, with classification against EU AI Act risk tiers, alignment to the WHO ethics and governance guidance for AI for health, and GDPR Article 9 controls for special-category data. *Updated 2026-04-27. By Impetora.* ## Key metrics - **Annex III §3** - EU AI Act risk classification for biometric and healthcare AI - **Article 9** - GDPR special-category controls embedded by default - **11d** - Median pilot deployment for non-SaMD scopes - **100%** - Outputs with reviewer-traceable audit pointers ## How AI is reshaping healthcare operations in 2026 Healthcare organisations sit on the largest unstructured-text problem in any regulated industry: discharge letters, referral notes, lab reports, prior-authorisation forms, consent paperwork, payer correspondence. Most of it never reaches a structured field, and the cost of that gap shows up as documentation burden, coding error, and avoidable delay in care. The WHO 2024 guidance on the ethics and governance of AI for health (https://www.who.int/publications/i/item/9789240029200) sets out six core principles - protecting autonomy, promoting safety, ensuring transparency, fostering responsibility, ensuring inclusiveness, promoting responsive AI - that any production deployment is expected to evidence. The FDA AI/ML SaMD action plan (https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device) and the EMA reflection paper on AI in the medicines lifecycle (https://www.ema.europa.eu/en/news/reflection-paper-artificial-intelligence-published) draw the same boundary on the regulated side: anything that contributes to a clinical decision is a regulated device pathway, anything that supports operations around the decision is not. The unsolved problem is not capability; it is the boundary between assistive and autonomous. Impetora ships systems that sit firmly on the assistive side, with explicit human sign-off, special-category data controls under GDPR Article 9, and the documentation a Notified Body or hospital information-governance committee will ask to see before go-live. ## Use cases we deliver for healthcare teams ### Clinical document extraction and structuring Discharge letters, referrals, and lab reports arrive as PDFs and scans. Clinicians and admin staff re-key key fields into the EHR. **70%** - Reduction in re-keying time, with field-level source pointers preserved ### Patient triage automation across digital channels Inbound patient messages, portal forms, and email queues mix urgent clinical questions with admin requests. Triage staff spend most of the day routing rather than resolving. **5x** - Faster routing to the right clinician or admin queue, with clinician override surfaced first ### Clinical decision support with explainability Guideline lookups, drug-interaction checks, and protocol references are scattered across PDFs and intranet pages. Clinicians spend cognitive cycles finding the source rather than weighing the decision. **Assistive only** - Reviewer-traceable evidence surfaced beside the clinician, never autonomous ### Medical coding and billing automation ICD-10, CPT, and DRG coding from physician notes is high-volume, error-sensitive, and a frequent source of payer denials and audit exposure. **0.5%** - Code-level error rate after evaluation tuning, with note-level audit pointers ### Compliance and consent-tracking automation Consent forms, DPIAs, and information-governance approvals live across SharePoint, email and paper. Demonstrating that a specific dataset has the right consent for a specific use is slow and error-prone at audit time. **Audit-ready** - Consent and lawful-basis chain reproducible per record, with citation to source ### Predictive care utilisation forecasting Bed occupancy, theatre scheduling, and outpatient demand fluctuate weekly. Operations teams forecast in spreadsheets that lag reality. **Weekly** - Operational forecasts with reasoning traces and named confidence bounds ## How TRACE applies to healthcare AI Trust. Healthcare AI sits inside the most sensitive category of personal data and the most consequential class of professional decisions. We classify every system against GDPR Article 9 (https://gdpr-info.eu/art-9-gdpr/) special-category controls, the EU AI Act (https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32024R1689) Annex III §3 high-risk scope, and the device pathway under the Medical Device Regulation (https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745) where applicable. Where a system would qualify as Software as a Medical Device, we say so up front and scope the conformity-assessment work into the engagement; we do not ship clinical-decision-making AI without the regulated route. Readiness. Before any model is selected, we run a 1 to 2 week workflow audit. Architecture. Production patterns specific to healthcare: FHIR-native exchange where supported, immutable storage of source documents in EU regions, versioned prompts with eval suites tied to clinician-reviewed gold sets, pseudonymisation at the boundary, shadow-mode rollouts. Citations and evidence. Every output links to the source document, the page, the prompt version, and the model run that produced it. ## Regulatory considerations for healthcare AI Healthcare AI is regulated under multiple overlapping frameworks. Under the EU AI Act Annex III §3, AI systems used for biometric categorisation and certain healthcare-adjacent uses are classified as high-risk, with mandatory conformity assessment, risk management, data governance, transparency, and human-oversight controls. Where the system performs a function intended for diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease, the Medical Device Regulation applies and a regulated SaMD pathway is required. GDPR Article 9 prohibits the processing of health data unless one of the listed conditions applies, with explicit consent, public-interest health, or healthcare-provision lawful bases the most common in practice. For US healthcare teams, the FDA AI/ML-based SaMD action plan (https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device) sets the regulatory direction for software functions that meet the device definition. The EMA reflection paper on AI in the medicines lifecycle (https://www.ema.europa.eu/en/news/reflection-paper-artificial-intelligence-published) extends the same posture to drug development and pharmacovigilance. The WHO ethics and governance guidance (https://www.who.int/publications/i/item/9789240029200) and the NICE evidence standards framework (https://www.nice.org.uk/about/what-we-do/our-programmes/evidence-standards-framework-for-digital-health-technologies) translate the regulatory direction into procurement and evidence expectations. ## How healthcare teams typically engage with us Three phases. The discovery sprint always comes first, and the cost of doing it is recovered the moment scope is locked correctly and the regulated boundary is named explicitly. ### 01 Discovery (1 to 2 weeks) Workflow audit, DPIA inputs and information-governance baseline, sample 30 days of real records, scope sign-off with named success metrics. Output is a written diagnosis with risk classification under the EU AI Act and an explicit determination of whether the system falls under MDR. ### 02 Build (4 to 12 weeks) Production architecture, eval suite tied to clinician-reviewed gold sets, FHIR-native data exchange where supported, shadow-mode rollout where the AI runs alongside the clinician or coder with output logged but not actioned, audit-log delivery aligned to the WHO transparency principle. ### 03 Operate (Ongoing) Quarterly drift reports, eval-set growth from real human corrections, model-version upgrades behind a regression suite, regulatory-update tracking across EU AI Act, MDR, GDPR, FDA and NICE. ## Frequently asked questions ### Is AI for healthcare data safe under GDPR Article 9? Yes, when the system is designed correctly. Health data is special-category and prohibited from processing unless an Article 9(2) condition applies, most commonly explicit consent, public-interest health, or the provision of healthcare under a contract with a regulated professional. We deploy on EU regions by default, sign DPAs that include zero-retention and no-training clauses for inference traffic, pseudonymise at the boundary, and produce a DPIA-ready data-flow diagram before any system goes live. ### Does Impetora build clinical-decision-making AI? No. Impetora ships assistive systems that surface evidence, structure documents, and accelerate operations around the clinical decision. Anything that performs a function intended for diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of disease falls under the Medical Device Regulation in the EU and the FDA SaMD framework in the US, and requires a conformity-assessment pathway. Where a client engagement requires that pathway, we say so explicitly during discovery and scope the regulated work into the proposal. ### How do you handle EU AI Act high-risk classification for healthcare AI? The EU AI Act classifies a number of healthcare-adjacent uses as high-risk under Annex III §3, which triggers obligations on risk management, data governance, technical documentation, record-keeping, transparency, human oversight, accuracy, robustness, and cybersecurity. We build conformity-assessment scaffolding into the system from week one: an ISO 42001-aligned governance memo, the technical documentation pack the regulation requires, an append-only audit log, and a documented human-in-the-loop step. ### What is the typical scope for a healthcare AI engagement? A first engagement targets one workflow with a measurable baseline, runs 4 to 12 weeks to production, and lands as a single signed-off system inside one EHR, RIS, LIS, or operations surface. Common scopes are: clinical document extraction across one or two document types; patient triage automation across one or two digital channels; medical coding automation across one or two specialties; consent and audit-readiness automation. ### Can the system integrate with EHRs and digital health platforms? Yes. The delivery layer is built around your data surface. We ship FHIR-native integrations where the source system supports them, HL7 v2 bridges where it does not, and queue-based bridges with idempotent writes for legacy systems. The audit log writes regardless of where the data lands. ### How accurate is medical coding automation in production? Production-grade deployments see code-level error rates of 0.4 to 0.7% on routine specialties after the first three weeks of evaluation tuning, against typical human-only baselines reported in industry studies. We baseline first, target a specific delta against your current process, and report against it weekly through the pilot. A coder always signs off; the AI structures and proposes, the human decides. ### Where is the data processed, and do you train on our records? By default, all processing and storage runs in EU regions on infrastructure under EU jurisdiction. We support regional pinning when a regulator or contract requires it. We do not train any model on your records. ### What does a healthcare AI engagement cost? Pricing is set after the discovery sprint, against your specific workflow, integration surface, and regulatory tier. We do not publish a flat rate because the scope variation across healthcare AI is wide. Submit a project with the workflow and rough volume, and we come back with a discovery proposal within one business day. Production deployments that sit on the regulated SaMD boundary include a conformity-assessment work package which is scoped explicitly in the proposal. ## About this service **AI for healthcare teams.** Custom AI systems for hospitals, clinics, payers and digital health platforms. Clinical document extraction, patient triage, decision support, medical coding, consent automation, utilisation forecasting. EU AI Act and GDPR Article 9-aligned, MDR-aware, audit-traceable.